新型冠状病毒肺炎疫情期间成分血捐献者体检征询防控策略探讨  

Prevention and control strategies of physical examination and health consultation for apheresis donation during the COVID-19 outbreak

作　　者：郑悦[1] 冯晴[1] 李春燕[1] 郭峻峰 余敏敏 黄爱平[1] 陈玲 ZHENG Yue;FENG Qing;LI Chunyan;GUO Junfeng;YU Minmin;HUANG Aiping;CHEN Ling(Zhejiang Blood Center,Hangzhou 310006,China)

机构地区：[1]浙江省血液中心,浙江杭州310006

出　　处：《中国输血杂志》2021年第6期646-649,共4页Chinese Journal of Blood Transfusion

摘　　要：目的探讨新型冠状病毒肺炎(COVID-19)疫情期间采用针对性的成分血捐献者健康征询和一般检查的防控策略的必要性和有效性。方法在2020年1月23日3月22日COVID-19疫情期间,本中心采取健康征询和一般检查三阶段防控策略,针对湖北输入期、本省疫情期、境外输入期各期的特点对成分血捐献者增加旅居史、接触史的征询和相关症状的排查。比较此疫情防控期间与2019年同期的健康征询和一般检查的不合格率,比较3个阶段的健康征询和一般检查项目的不合格率,以及其中初次和固定成分血捐献者的不合格率。结果成分血捐献者在COVID-19疫情期间与2019年同期的健康征询不合格率为2.29%(100/4 371) vs 1.65%(78/4 740)(P<0.05),一般检查不合格率为3.75%(160/4 264) vs 1.07%(50/4 655)(P<0.01)。湖北输入期(1月23日31日)、本省疫情期(2月1日3月1日)、境外输入期(3月2日22日)健康征询不合格率分别为2.32%(9/388) vs 3.49%(68/1 947)vs 1.13%(23/2 036)(P<0.01),一般检查不合格率分别为2.12%(8/378) vs 3.68%(69/1 877) vs 4.13%(83/2 009)(P>0.05);旅居接触史不合格率在本省疫情期最高为2.05%(40/1 947),呼吸道不合格率在湖北输入期最高为1.29%(5/388);血压脉搏不合格率分别为1.85%(7/378) vs 3.57%(67/1 877) vs 4.08(82/2 009)(P>0.05)。初次和固定成分血捐献者的健康征询不合格率分别为5.86%(38/649) vs 1.65%(61/3696)(P<0.01),一般检查不合格率分别为5.79%(35/604) vs 3.41%(124/3635)(P<0.01)。结论 COVID疫情期间成分血捐献者健康征询和一般检查不合格率明显上升;制定并采取疫情期间具有针对性的征询策略以最大限度阻断和减少COVID-19传播的风险很有必要。Objective To discuss the prevention and control strategies of physical examination and health consultation for apheresis donation during the COVID-19 outbreak,and to verify its necessity and efficiency. Methods A three-stage( Hubei import period,Jan 23 to 31;local( Zhejiang) epidemic period( Feb 1 to Mar 1);overseas import period,Mar 2 to22) prevention and control strategy for physical examination and health consultation during the COVID-19 outbreak from January 23 to March 22,2020 was adopted by our center,and the consultation of residence history,contact history,and the investigation of related symptoms were added to health consultation.The deferral rates of health consultation and physical examination during the COVID-19 outbreak were compared with the same period in 2019. The deferral rates in each stage were compared,containing those contributed by first-time and regular apheresis donors.Results The deferral rates of health consultation during the epidemic period and the same period in 2019 were 2. 31%( 100/4 371) vs 1. 62%( 78/4 740)( P <0. 05),the physical examination 3. 75%( 160/4 264) vs 1. 07%( 50/4 655)( P<0. 01).The deferral rates of health consultation during the three stages were 2. 32%( 9/388) vs 3. 49%( 68/1 947) vs 1. 13%( 23/2 036) respectively( P < 0. 01),physical examination 2. 12%( 8/378) vs 3. 68%( 69/1 877) vs 4. 13%( 83/2 009)( P>0. 05) The deferral rate of travel contact history was the highest at 2. 05%( 40/1947) during local epidemic period,and respiratory symptoms at 1. 29%( 5/388)during Hubei import period. The deferral rates of blood pressure during the three stages were1. 85%( 7/378) vs 3. 57%( 67/1877) vs 4. 08( 82/2009)( P>0. 05). The deferral rate of health consultation and physical examination in first-time and regular apheresis donors were 5. 86%( 38/649) vs 1. 65%( 61/3 696) and 5. 79%( 35/604) vs 3. 41%( 124/3 635)( P< 0. 01).Conclusion The deferral rates of health consultation and physical examination increased significantly during the COVID-19 epidemic. Therefore,it is nece

关 键 词：新型冠状病毒肺炎 成分血捐献者 健康征询 献血者体检 血液安全 

分 类 号：R563.1[医药卫生—呼吸系统] R443[医药卫生—内科学]